The sickle cell trait and end stage renal disease in Salvador, Brazil.

BACKGROUND:Carriers of the sickle cell trait (HbAS) usually remain asymptomatic. However, under conditions of low tissue oxygenation, red blood cell sickling and vascular obstruction may develop. Chronic kidney disease (CKD) can arise from conditions promoting low-oxygen in kidney tissue, which may...

Full description

Bibliographic Details
Main Authors: Dona J Alladagbin, Paula N Fernandes, Maria B Tavares, Jean T Brito, Geraldo G S Oliveira, Luciano K Silva, Nadia A Khouri, Marilia B Oliveira, Tatiana Amorim, Cácia M Matos, Guilherme S Ribeiro, Antônio A Lopes, Marilda S Gonçalves, Washington L C Dos-Santos
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0209036
_version_ 1819260186953515008
author Dona J Alladagbin
Paula N Fernandes
Maria B Tavares
Jean T Brito
Geraldo G S Oliveira
Luciano K Silva
Nadia A Khouri
Marilia B Oliveira
Tatiana Amorim
Cácia M Matos
Guilherme S Ribeiro
Antônio A Lopes
Marilda S Gonçalves
Washington L C Dos-Santos
author_facet Dona J Alladagbin
Paula N Fernandes
Maria B Tavares
Jean T Brito
Geraldo G S Oliveira
Luciano K Silva
Nadia A Khouri
Marilia B Oliveira
Tatiana Amorim
Cácia M Matos
Guilherme S Ribeiro
Antônio A Lopes
Marilda S Gonçalves
Washington L C Dos-Santos
author_sort Dona J Alladagbin
collection DOAJ
description BACKGROUND:Carriers of the sickle cell trait (HbAS) usually remain asymptomatic. However, under conditions of low tissue oxygenation, red blood cell sickling and vascular obstruction may develop. Chronic kidney disease (CKD) can arise from conditions promoting low-oxygen in kidney tissue, which may be aggravated by the presence of the sickle cell trait. In addition, CKD can arise from other genetic traits. AIM:To compare the frequency of HbAS among hemodialysis patients and the general newborn population of Salvador (Bahia-Brazil), as well as to investigate the frequencies of apolipoprotein L1 risk variants in patients undergoing hemodialysis. METHODS:A cross-sectional study included 306 patients with ESRD (End Stage Renal Disease) on hemodialysis for no more than three years. Hemoglobin profiles were characterized by high-performance liquid chromatography. To estimate the sickle cell trait frequency in the general population of Salvador, we analyzed data collected by a local neonatal screening program between 2011 and 2016. To exclude the potential contributing effect of the apolipoprotein L1 (APOL1) gene variants, we performed genotyping by PCR and DNA sequencing of 45 patients. RESULTS:The frequency of HbAS was significantly higher in hemodialysis patients (9.8%) than in the general population (4.6%): Odds Ratio = 2.32 (95% CI = 1.59-3.38). No differences in demographic, clinical or laboratory data were found among patients with or without the sickle cell trait. The frequency of patients with none, one or two APOL1 risk haplotypes (G1 and G2) for CKD were 80%, 18% and 2%, respectively. CONCLUSIONS:The frequency of the sickle cell trait is higher in patients with ESRD on hemodialysis compared to the general population. APOL1 haplotypes do not seem to be the determinant of ESRD in these patients.
first_indexed 2024-12-23T19:21:55Z
format Article
id doaj.art-827ac5349c7a4824b3cc94e8e74eeed1
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T19:21:55Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-827ac5349c7a4824b3cc94e8e74eeed12022-12-21T17:34:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011312e020903610.1371/journal.pone.0209036The sickle cell trait and end stage renal disease in Salvador, Brazil.Dona J AlladagbinPaula N FernandesMaria B TavaresJean T BritoGeraldo G S OliveiraLuciano K SilvaNadia A KhouriMarilia B OliveiraTatiana AmorimCácia M MatosGuilherme S RibeiroAntônio A LopesMarilda S GonçalvesWashington L C Dos-SantosBACKGROUND:Carriers of the sickle cell trait (HbAS) usually remain asymptomatic. However, under conditions of low tissue oxygenation, red blood cell sickling and vascular obstruction may develop. Chronic kidney disease (CKD) can arise from conditions promoting low-oxygen in kidney tissue, which may be aggravated by the presence of the sickle cell trait. In addition, CKD can arise from other genetic traits. AIM:To compare the frequency of HbAS among hemodialysis patients and the general newborn population of Salvador (Bahia-Brazil), as well as to investigate the frequencies of apolipoprotein L1 risk variants in patients undergoing hemodialysis. METHODS:A cross-sectional study included 306 patients with ESRD (End Stage Renal Disease) on hemodialysis for no more than three years. Hemoglobin profiles were characterized by high-performance liquid chromatography. To estimate the sickle cell trait frequency in the general population of Salvador, we analyzed data collected by a local neonatal screening program between 2011 and 2016. To exclude the potential contributing effect of the apolipoprotein L1 (APOL1) gene variants, we performed genotyping by PCR and DNA sequencing of 45 patients. RESULTS:The frequency of HbAS was significantly higher in hemodialysis patients (9.8%) than in the general population (4.6%): Odds Ratio = 2.32 (95% CI = 1.59-3.38). No differences in demographic, clinical or laboratory data were found among patients with or without the sickle cell trait. The frequency of patients with none, one or two APOL1 risk haplotypes (G1 and G2) for CKD were 80%, 18% and 2%, respectively. CONCLUSIONS:The frequency of the sickle cell trait is higher in patients with ESRD on hemodialysis compared to the general population. APOL1 haplotypes do not seem to be the determinant of ESRD in these patients.https://doi.org/10.1371/journal.pone.0209036
spellingShingle Dona J Alladagbin
Paula N Fernandes
Maria B Tavares
Jean T Brito
Geraldo G S Oliveira
Luciano K Silva
Nadia A Khouri
Marilia B Oliveira
Tatiana Amorim
Cácia M Matos
Guilherme S Ribeiro
Antônio A Lopes
Marilda S Gonçalves
Washington L C Dos-Santos
The sickle cell trait and end stage renal disease in Salvador, Brazil.
PLoS ONE
title The sickle cell trait and end stage renal disease in Salvador, Brazil.
title_full The sickle cell trait and end stage renal disease in Salvador, Brazil.
title_fullStr The sickle cell trait and end stage renal disease in Salvador, Brazil.
title_full_unstemmed The sickle cell trait and end stage renal disease in Salvador, Brazil.
title_short The sickle cell trait and end stage renal disease in Salvador, Brazil.
title_sort sickle cell trait and end stage renal disease in salvador brazil
url https://doi.org/10.1371/journal.pone.0209036
work_keys_str_mv AT donajalladagbin thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT paulanfernandes thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT mariabtavares thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT jeantbrito thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT geraldogsoliveira thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT lucianoksilva thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT nadiaakhouri thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT mariliaboliveira thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT tatianaamorim thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT caciammatos thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT guilhermesribeiro thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT antonioalopes thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT marildasgoncalves thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT washingtonlcdossantos thesicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT donajalladagbin sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT paulanfernandes sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT mariabtavares sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT jeantbrito sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT geraldogsoliveira sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT lucianoksilva sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT nadiaakhouri sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT mariliaboliveira sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT tatianaamorim sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT caciammatos sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT guilhermesribeiro sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT antonioalopes sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT marildasgoncalves sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil
AT washingtonlcdossantos sicklecelltraitandendstagerenaldiseaseinsalvadorbrazil